Antibody responses to envelope glycoproteins in HIV-1 infection - Wikidata - awgldk - TriplyDB

Antibody responses to envelope glycoproteins in HIV-1 infection

Antibody responses to envelope glycoproteins in HIV-1 infection

http://www.wikidata.org/entity/Q26991572

about

The germinal center antibody response in health and disease HIV Genome-Wide Protein Associations: a Review of 30 Years of Research HIV-Host Interactions: Implications for Vaccine Design Anergic B Cells: Precarious On-Call Warriors at the Nexus of Autoimmunity and False-Flagged Pathogens Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1 The HIV glycan shield as a target for broadly neutralizing antibodies Elimination of HIV-1-infected cells by broadly neutralizing antibodies Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design Perspectives for immunotherapy: which applications might achieve an HIV functional cure?Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.Survivors Remorse: antibody-mediated protection against HIV-1.Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies.Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity.Engineering antibody-like inhibitors to prevent and treat HIV-1 infection.Clonify: unseeded antibody lineage assignment from next-generation sequencing data Lessons learned from human HIV vaccine trials.Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.Antibody 10-1074 suppresses viremia in HIV-1-infected individuals Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection.HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.Discrete partitioning of HIV-1 Env forms revealed by viral capture.HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects.Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1.Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization.New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus Host Anti-antibody Responses Following Adeno-associated Virus-mediated Delivery of Antibodies Against HIV and SIV in Rhesus Monkeys Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice.CXCL13 is a plasma biomarker of germinal center activity.

P2860

Q26745929-0FFF6454-7DF8-45E2-98CE-9E81A305C3E5 Q26746070-E88BE773-F557-4A3A-8F27-DDB9CAF08CB1 Q26765966-AC61767F-2216-48F3-9B78-3F325F6087D2 Q26774672-4990FA75-6906-48F6-926E-BDB4DFA238ED Q26775082-EF52F0BE-E59A-467D-B7CB-3E0018DAB575 Q26782237-7164D09A-49A7-4822-97E5-4CD2E5621196 Q26786540-B70526A6-3C06-4722-9FBA-F16BF55F172F Q27329126-D34BEEBD-BF08-4B5C-8C82-C9EB6E7EFAE2 Q28075274-C476B536-1EF7-43C2-9486-08468563D752 Q28078726-8E6EB744-3FBD-46C8-8055-D0C0A590E62A Q30234773-8DC0C9C9-40D2-46FA-9F9B-C1298EB3347A Q30238730-9480AEDA-9BF5-4E63-8102-EB9512724877 Q30352300-58836233-A26F-4274-A406-96A582021003 Q30391094-8CFD3DFA-68C7-48BA-8F07-D2B4A574EAC5 Q30490945-9DD865AE-E4F5-4004-BAA0-784A3FA28149 Q31082802-F4800ED6-65BE-486D-BAF3-DFD7441A6B53 Q33557844-E2EBE9DE-A5F9-405C-8750-1EE91F8468E1 Q33592852-37DB723B-8320-4FDC-B0CF-07A23C97BA8F Q33631104-C8CE457C-1F98-494B-99F6-43B9FBF62323 Q33638320-68CDBA12-3FC1-474B-81B9-6B5E241165F7 Q33786443-1E3F5D9B-D7D3-426B-AB68-59C554EE46E1 Q33786447-D9805BC2-599E-49D2-9E02-542C559E5215 Q33804531-0E04858B-0379-4361-924A-BBA6B7BACCA0 Q35894094-68136755-E84B-43B9-8BEA-D515E6A8EA7A Q35925331-5EAECAB1-7CEB-4217-A827-A618C14CC32B Q35969973-3DBD6060-A8A4-4CE5-A6D9-0C4BB3CBEEC4 Q35985519-E1DFDEEE-D2FB-43B1-B0BC-EC54EA133BB5 Q36088254-AC00607A-A207-436C-9066-323E0538F1E3 Q36097352-A529F55A-D7DB-4BF2-A127-1B2453719905 Q36246646-9886E59C-5261-4938-A191-F413C11E60D2 Q36263513-3282D015-1685-49D6-AB40-9836E694CBE8 Q36281210-BC327F56-F170-4E8D-82CE-3239A051D134 Q36294782-8B29E58D-991C-423A-8183-605969A0E7FD Q36334359-A2DF93DB-D7B4-4BB5-BF2C-9A9066AA5333 Q36433894-F97E05AE-DA5E-4156-B879-63F0261A6725 Q36434196-CB9B76F3-30FB-465F-A20F-A4C159A7D5D5 Q36450159-4827C9A3-C131-4C5C-8DF1-A1AEE141CBC9 Q36582838-0112E072-2A94-4E3F-9E70-297A0F10FB07 Q36627503-277B6A6A-A537-45C1-967F-233E3A756ED4 Q36684710-BE8527DB-4CE5-4C31-9E80-97B46AF9281E

P2860

Antibody responses to envelope glycoproteins in HIV-1 infection

http://www.wikidata.org/entity/Q26991572

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Antibody responses to envelope glycoproteins in HIV-1 infection

@ast

Antibody responses to envelope glycoproteins in HIV-1 infection

@en

Antibody responses to envelope glycoproteins in HIV-1 infection

@nl

type

label

Antibody responses to envelope glycoproteins in HIV-1 infection

@ast

Antibody responses to envelope glycoproteins in HIV-1 infection

@en

Antibody responses to envelope glycoproteins in HIV-1 infection

@nl

prefLabel

Antibody responses to envelope glycoproteins in HIV-1 infection

@ast

Antibody responses to envelope glycoproteins in HIV-1 infection

@en

Antibody responses to envelope glycoproteins in HIV-1 infection

@nl

P1433

Q26991572-ACC48BD6-822E-4987-97A8-4C62D29EDB21

P1476

Q26991572-9D8854AE-3C25-4EF3-AD5F-C94DFEDFF35A

P2093

Q26991572-469C15FB-7413-418F-886F-0D4FB930019D

P2860

Q26991572-02F1FE51-30A5-49DD-8F25-8F136F354730

Q26991572-0361DF3F-32D9-440A-8707-65FE515D320E

Q26991572-0BD8ED88-294B-42E8-BEBB-580055FCD640

Q26991572-0C2268E1-D6D3-4D26-9F07-D23674DE861B

Q26991572-15056C35-EDC9-4862-BF7A-7715A5BCD472

Q26991572-15059F1E-7893-411F-8D82-169A82DA957A

Q26991572-172A4361-21C0-4516-884A-380F732EECEA

Q26991572-199054AD-D461-43D3-8A31-0D106FA4192E

Q26991572-19E04DEF-DE8F-461A-BF6D-FD47E45E9CD7

Q26991572-1A2B3354-91F9-4128-B329-494395237114

P304

Q26991572-3004D5DF-DAFC-4C30-993B-1287DE5BA72B

P31

Q26991572-2E3945E6-F658-446B-B8EE-1A98E75A67E5

P3181

Q26991572-E0D73FD6-0B68-4501-99D2-AFD3C5827BF3

P356

Q26991572-CB81BDF2-E6FB-43B2-AFE8-B7D81E44AF29

P407

Q26991572-B5A646CD-D6A9-4B6C-9F49-A4DABFCB9297

P433

Q26991572-1C771D0F-644D-4A43-93A1-4344AF75BBC1

P478

Q26991572-784478F6-E729-43B1-A528-97BCFFC51D51

P50

Q26991572-0B7A4020-8B40-4A57-B4C5-52A05D5B9850

P577

Q26991572-12CC456C-B6E6-4D08-8E31-C7668E8BEA49

P5875

Q26991572-B8406E54-911A-4A94-B868-7EF34D11390B

P698

Q26991572-4D13A01E-923C-44C2-89A9-779CF847B438

P921

Q26991572-89CD6A05-EF75-455D-852A-626F046EC846

P932

Q26991572-251B8833-FD2F-489E-BA90-30E6B54DBA09

P3181

P356

P1433

Nature Immunology

P1476

Antibody responses to envelope glycoproteins in HIV-1 infection

@en

P2093

Dennis R Burton

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro

Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals

Structural insights on the role of antibodies in HIV-1 vaccine and therapy

A Blueprint for HIV Vaccine Discovery

HIV-1 neutralizing antibodies: understanding nature's pathways

The Antibody Response against HIV-1

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection

Virological features associated with the development of broadly neutralizing antibodies to HIV-1

Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site

P304

571-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

244701

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NI.3158

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277086610

http://www.w3.org/2001/XMLSchema#string

P698

25988889

http://www.w3.org/2001/XMLSchema#string

P921

P932

4834917

http://www.w3.org/2001/XMLSchema#string